Metabolomics and proteomics reveal blocking argininosuccinate synthetase 1 alleviates colitis in mice
Open Access
- 30 July 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Abstract
To date, treating ulcerative colitis (UC) remains a significant challenge due to its complex etiology. In this study, metabolomics and proteomics analysis for multi-center cohorts reveal that both serum arginine levels and the rate-limiting enzyme argininosuccinate synthetase 1 (ASS1) are significantly elevated in UC patients. Exogenous arginine infusion and ASS1 overexpression exacerbate the pathological features of colitis in mice, while inhibiting or silencing ASS1 offers protection against experimental colitis. The induction of ASS1 is accompanied by increased levels of acetylated H3 and trimethylated H3K4, along with decreased levels of dimethyl H3K9 around the ASS1 promoters, suggesting epigenetic activation of ASS1 in colitis. The ASS1/arginine axis triggers mTOR and iNOS activation and induces gut microbiota dysbiosis, leading to experimental colitis. Additionally, we identify a screened compound, C-01, which significantly improves colitis by highly binding to ASS1. Our findings suggest that ASS1 could be a promising target for UC treatment.Keywords
This publication has 92 references indexed in Scilit:
- Illuminating the structure–function landscape of an evolutionary nonconserved motif in the arginases of Helicobacter gastric pathogensIUBMB Life, 2023
- SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1αJournal of Molecular Medicine, 2020
- Metabolic pathways of L-arginine and therapeutic consequences in tumorsAdvances in Medical Sciences, 2019
- Gut microbiota in the pathogenesis of inflammatory bowel diseaseClinical Journal of Gastroenterology, 2017
- mTORC1 signaling and IL‐17 expression: Defining pathways and possible therapeutic targetsEuropean Journal of Immunology, 2015
- Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2015
- Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severityInflammatory Bowel Diseases, 2010
- Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitisInternational Journal of Colorectal Disease, 2005
- Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline–arginine regeneration pathwayBiochemical Pharmacology, 2005
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004